Ind-Swift Laboratories Ltd
company logo

Ind-Swift Laboratories Ltd

Ind-Swift Labs. Share Price

Pharmaceuticals
Small Cap

-

0 (0%)


Invest in Ind-Swift Laboratories Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Ind-Swift Laboratories Ltd Performance

-

-

-

-


-

-

-

-

-

Ind-Swift Laboratories Ltd Fundamentals

Read More

601.80Cr

5.89

0.59

0.61

17.29

0%

171.20

Ind-Swift Laboratories Ltd Financials

Ind-Swift Laboratories Ltd Financialsright-arrow

Ind-Swift Laboratories Ltd Shareholding Pattern

Ind-Swift Laboratories Ltd Delivery and Volume

About Ind-Swift Laboratories Ltd

Ind-Swift Laboratories Ltd is a part of the Ind-swift Group and is based at Chandigarh, India. The company manufactures and sells active pharmaceutical ingredients (API). Their product pipeline consists of 25 products, which includes drugs, which include Clarithromycin (Macrolide antibiotic), Atorva

N R Munjal

1995

INDSWFTLAB

NameDesignation
Gopal Munjal Director
N R MunjalChairman & Managing Director
Himanshu JainJoint Managing Director
Pradeep VermaCompany Sec. & Compli. Officer
S R Mehta Chairman
Rishav MehtaExecutive Director
V R Mehta Director
S P SharmaIndependent Director
K M S Nambiar Director
Neerja ChathleyIndependent Director
J K Kakkar Director
Ashwani K VigIndependent Director
Sahil MunjalExecutive Director
Pardeep Verma Company Secretary
H P S Chawla Director
Rajendra Kumar GuptaIndependent Director
Pradeep Kumar Director
T S Bhattacharya Independent Director
R K Ummat Independent Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Ind-Swift Laboratories Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Ind-Swift Laboratories Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Ind-Swift Laboratories Ltd's share price is ₹100.65 as of 2024-11-23.
Ind-Swift Laboratories Ltd's P/E ratio is 5.89 times as of 2024-11-23.
Ind-Swift Laboratories Ltd's most recent financial reports indicate a price-to-book ratio of 0.59, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Ind-Swift Laboratories Ltd's market capitalization is ₹601.8 Cr as on 2024-11-23.
The current financial records of Ind-Swift Laboratories Ltd show a 18.99% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Ind-Swift Laboratories Ltd's most recent financial filings, the company has a total asset value of ₹577.38, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Ind-Swift Laboratories Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Ind-Swift Laboratories Ltd's 52-week high and low as of 2024-11-23 are ₹101.55 and ₹100.65, respectively.